PBH Prestige Consumer Healthcare
- 79.230
- +0.480+0.61%
- 79.230
- 0.0000.00%
Prestige Consumer Healthcare News
Sidoti Initiates Prestige Consumer Healthcare(PBH.US) With Hold Rating, Announces Target Price $90
Prestige Consumer Hlthcr Price Target Maintained With a $95.00/Share by DA Davidson
Prestige Consumer Analyst Ratings
D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating
D.A. Davidson Sticks to Their Buy Rating for Prestige Consumer Healthcare (PBH)
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93
Prestige Consumer Hlthcr Price Target Raised to $76.00/Share From $70.00 by Jefferies
Prestige Consumer Analyst Ratings
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $81
D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $95
D.A. Davidson Remains a Buy on Prestige Consumer Healthcare (PBH)
Prestige Consumer Analyst Ratings
Prestige Consumer Analyst Ratings
Prestige Consumer Analyst Ratings
Prestige Consumer Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
Analysts Are Bullish on Top Healthcare Stocks: Nyxoah (NYXH), Prestige Consumer Healthcare (PBH)
Analysts Are Bullish on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), Madrigal Pharmaceuticals (MDGL)
D.A. Davidson Sticks to Their Hold Rating for Prestige Consumer Healthcare (PBH)
No Data